Rare Abdominal Cancers Treatment in Hyderabad

For peritoneal mesothelioma — the most important rare peritoneal malignancy — CRS + HIPEC has transformed the disease from uniformly fatal to a condition where median survival exceeds 5 years in selected patients, with long-term survivors documented. Eligibility criteria are similar to other peritoneal malignancies: adequate performance status, absence of significant pleural disease, and complete cytoreduction achievable.

For adrenocortical carcinoma, radical adrenalectomy with en-bloc resection of any involved adjacent structures is the only curative treatment. Laparoscopic adrenalectomy is contraindicated for ACC — open surgery with adequate margins is required. Mitotane (adrenolytic drug) is used as adjuvant treatment and for metastatic disease. For Stage IV ACC, multimodal treatment combining surgery with mitotane, EDP chemotherapy, and targeted approaches is discussed at our MDT.

For any rare abdominal cancer, my recommendation is the same: come for a specialist consultation before committing to any surgical or systemic treatment plan. Bring all imaging, pathology, and previous operative notes. An hour of specialist evaluation can completely change the trajectory of treatment — and in rare cancers, expertise is scarce enough that this visit can make a life-or-death difference.